NASDAQ:AWH Aspira Women's Health (AWH) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free AWH Stock Alerts $3.26 -0.14 (-4.12%) (As of 01:24 PM ET) Add Compare Share Share Today's Range$3.20▼$3.4050-Day Range$2.64▼$4.9652-Week Range$2.31▼$6.75Volume3,130 shsAverage Volume30,201 shsMarket Capitalization$40.23 millionP/E RatioN/ADividend YieldN/APrice Target$4.45 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Aspira Women's Health alerts: Email Address Aspira Women's Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside36.5% Upside$4.45 Price TargetShort InterestBearish2.52% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.24) to ($0.86) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.67 out of 5 starsMedical Sector772nd out of 907 stocksDiagnostic Substances Industry10th out of 11 stocks 3.3 Analyst's Opinion Consensus RatingAspira Women's Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAspira Women's Health has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.52% of the float of Aspira Women's Health has been sold short.Short Interest Ratio / Days to CoverAspira Women's Health has a short interest ratio ("days to cover") of 6.1.Change versus previous monthShort interest in Aspira Women's Health has recently increased by 26.23%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAspira Women's Health does not currently pay a dividend.Dividend GrowthAspira Women's Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AWH. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Aspira Women's Health this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for AWH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Aspira Women's Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aspira Women's Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.30% of the stock of Aspira Women's Health is held by insiders.Percentage Held by InstitutionsOnly 12.19% of the stock of Aspira Women's Health is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aspira Women's Health are expected to grow in the coming year, from ($1.24) to ($0.86) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aspira Women's Health is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aspira Women's Health is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide About Aspira Women's Health Stock (NASDAQ:AWH)Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company's products include Ova1, a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker reflex test; and Ova1Plus, a reflex offering. Its product pipeline includes OvaWatch, a non-invasive blood-based risk assessment test to determine ovarian cancer risk for patients with an adnexal mass; and Endocheck, an in-development non-invasive blood test designed as an aid in the identification of endometriosis for patients with suspected endometriosis earlier in their prognosis journey. In addition, the company operates Aspira Synergy, a testing platform and cloud service; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories. The company distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. It has a research agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas.Read More AWH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AWH Stock News HeadlinesApril 9, 2024 | globenewswire.comAspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in CaliforniaApril 5, 2024 | msn.comAspira Women's Health files to sell 1.57M shares for holdersApril 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.April 3, 2024 | benzinga.comAspira Womens Health Stock (NASDAQ:AWH), Analyst Ratings, Price Targets, PredictionsApril 1, 2024 | msn.comAspira Women’s Health Inc. (NASDAQ:AWH) Q4 2023 Earnings Call TranscriptMarch 30, 2024 | seekingalpha.comAspira Women's Health Inc. (AWH) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | msn.comAspira Women’s Health GAAP EPS of -$0.30 beats by $0.15, revenue of $2.13M misses by $0.42MMarch 28, 2024 | finanznachrichten.deAspira Women's Health Inc.: Aspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial ResultsApril 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.March 28, 2024 | finance.yahoo.comAspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | globenewswire.comAspira Women's Health Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 27, 2024 | stockhouse.comAspira Women's Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and CallMarch 27, 2024 | benzinga.comA Preview Of Aspira Womens Health's EarningsMarch 25, 2024 | finance.yahoo.comAspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and CallMarch 21, 2024 | finance.yahoo.comAspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor ConferenceMarch 21, 2024 | globenewswire.comAspira Women's Health to Present at the MedInvest Biotech & Pharma Investor ConferenceMarch 20, 2024 | stockhouse.comAspira Women's Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as PresidentMarch 18, 2024 | finance.yahoo.comAspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as PresidentMarch 11, 2024 | finance.yahoo.comAspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024March 11, 2024 | globenewswire.comAspira Women's Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024February 22, 2024 | finance.yahoo.comAspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer ConferenceFebruary 22, 2024 | globenewswire.comAspira Women's Health to Present at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer ConferenceFebruary 21, 2024 | benzinga.comFirst Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health StocksFebruary 12, 2024 | finance.yahoo.comAspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)February 6, 2024 | finance.yahoo.comAspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the PhilippinesJanuary 25, 2024 | markets.businessinsider.comAspira Women's Health Announces $5.5 Mln Direct Offering, Private Placement; Stock Up In Pre-marketJanuary 25, 2024 | finance.yahoo.comOptimizeRx Announces Strategic Board Changes to Support Growth and Evolving LandscapeSee More Headlines Receive AWH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aspira Women's Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today4/25/2024Next Earnings (Estimated)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:AWH CUSIPN/A CIK926617 Webwww.aspirawh.com Phone512-519-0400Fax512-439-6908Employees64Year FoundedN/APrice Target and Rating Average Stock Price Target$4.45 High Stock Price Target$5.60 Low Stock Price Target$3.30 Potential Upside/Downside+32.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($12.0050) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,690,000.00 Net Margins-176.74% Pretax Margin-182.32% Return on Equity-1,099.32% Return on Assets-189.56% Debt Debt-to-Equity RatioN/A Current Ratio1.03 Quick Ratio0.99 Sales & Book Value Annual Sales$9.15 million Price / Sales4.53 Cash FlowN/A Price / Cash FlowN/A Book Value($0.23) per share Price / Book-14.61Miscellaneous Outstanding Shares12,340,000Free Float11,813,000Market Cap$41.46 million OptionableNo Data Beta1.61 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Torsten Hombeck Ph.D. (Age 54)Senior VP & CFO Comp: $374.14kMs. Minh Merchant (Age 51)General Counsel & Corporate Secretary Comp: $433.41kDr. Sandra Milligan J.D. (Age 60)M.D., President Ms. Michelle SniderSenior Vice President of Commercial Strategy & OperationsKey CompetitorsImmuCellNASDAQ:ICCCARCA biopharmaNASDAQ:ABIOOncoCyteNASDAQ:OCXCardio DiagnosticsNASDAQ:CDIOVolitionRxNYSE:VNRXView All CompetitorsInsiders & InstitutionsB. Riley Wealth Advisors Inc.Bought 53,997 shares on 3/15/2024Ownership: 1.735%Quantum Private Wealth LLCBought 21,788 shares on 1/30/2024Ownership: 0.485%Nicole SandfordBought 5,000 shares on 12/6/2023Total: $16,800.00 ($3.36/share)Minh Hoang MerchantSold 980 sharesTotal: $3,302.60 ($3.37/share)Torsten HombeckBought 2,246 shares on 9/8/2023Total: $9,657.80 ($4.30/share)View All Insider TransactionsView All Institutional Transactions AWH Stock Analysis - Frequently Asked Questions Should I buy or sell Aspira Women's Health stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aspira Women's Health in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" AWH shares. View AWH analyst ratings or view top-rated stocks. What is Aspira Women's Health's stock price target for 2024? 2 Wall Street research analysts have issued 12 month price objectives for Aspira Women's Health's shares. Their AWH share price targets range from $3.30 to $5.60. On average, they predict the company's share price to reach $4.45 in the next year. This suggests a possible upside of 36.5% from the stock's current price. View analysts price targets for AWH or view top-rated stocks among Wall Street analysts. How have AWH shares performed in 2024? Aspira Women's Health's stock was trading at $4.08 at the beginning of 2024. Since then, AWH stock has decreased by 20.1% and is now trading at $3.26. View the best growth stocks for 2024 here. Are investors shorting Aspira Women's Health? Aspira Women's Health saw a increase in short interest in April. As of April 15th, there was short interest totaling 169,400 shares, an increase of 26.2% from the March 31st total of 134,200 shares. Based on an average daily volume of 27,900 shares, the days-to-cover ratio is currently 6.1 days. Approximately 2.5% of the company's stock are short sold. View Aspira Women's Health's Short Interest. When is Aspira Women's Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our AWH earnings forecast. How were Aspira Women's Health's earnings last quarter? Aspira Women's Health Inc. (NASDAQ:AWH) issued its quarterly earnings results on Thursday, March, 28th. The company reported ($0.30) EPS for the quarter, topping the consensus estimate of ($0.39) by $0.09. The company earned $2.13 million during the quarter, compared to the consensus estimate of $2.70 million. Aspira Women's Health had a negative net margin of 176.74% and a negative trailing twelve-month return on equity of 1,099.32%. When did Aspira Women's Health's stock split? Shares of Aspira Women's Health reverse split on the morning of Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What is Scott A. Carmilani's approval rating as Aspira Women's Health's CEO? 33 employees have rated Aspira Women's Health Chief Executive Officer Scott A. Carmilani on Glassdoor.com. Scott A. Carmilani has an approval rating of 92% among the company's employees. This puts Scott A. Carmilani in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 97.0% of employees surveyed would recommend working at Aspira Women's Health to a friend. What other stocks do shareholders of Aspira Women's Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aspira Women's Health investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and How do I buy shares of Aspira Women's Health? Shares of AWH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AWH) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspira Women's Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
